AtaiBeckley Inc. ATAI

NAS: ATAI | ISIN: NL0015000DX5 5/08/2026

7,220 USD (+0,56%)

(+0,56%) 5/08/2026

Grafiek AtaiBeckley Inc.

Grafiek AtaiBeckley Inc.

1 dag1d 0,56%
1 week1w 0,56%
1 maand1m 45,56%
3 maanden3m 73,14%
6 maanden6m 91,51%
1 jaar1j 72,32%
5 jaar5j -49,79%

AtaiBeckley Inc. in het nieuws

Toon enkel gratis nieuws

4 augustus 2026 · Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? · Persbericht

21 juli 2026 · Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? · Persbericht

21 juli 2026 · Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates · Persbericht

17 juli 2026 · Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time · Persbericht

17 juli 2026 · Are ATAI, FHB, PATK Obtaining Fair Deals for their Shareholders? · Persbericht

16 juli 2026 · Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions · Persbericht

9 maart 2026 · CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions · Persbericht

27 februari 2026 · Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments · Persbericht

20 november 2025 · Enhanced Fortifies Executive Leadership Team & Board of Directors · Persbericht

3 juni 2025 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders · Persbericht

Profiel AtaiBeckley Inc.

Commerciële diensten

Diverse commerciële diensten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe